Clinical Trial Update: A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing infliximab-antimetabolites combination therapy to anti-metabolites monotherapy and to infliximab monotherapy in Crohn's disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Infliximab (infliximab)
• antimetabolites (antimetabolites)

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: Crohn's Disease | Phase 4 | Status: COMPLETED